European acquisitions to boost Aurobindo's revenues

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

European acquisitions to boost Aurobindo's revenues

Aurobindo Pharma Ltd, the Rs 1,472-crore pharma major, is upbeat on the European markets, following its two key acquisitions in 2006. With the UK-based Milpharm Ltd and the Netherlands-based Pharmacin International in its fold, the company expects to substantially boost its revenues in the fiscal 2007-08.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo Pharma buys Dutch firm Pharmacin Aurobindo receives approval from MCC South Africa Aurobindo bags yet another ANDA approval from USFDA ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Ltd , the Rs 1,472-crore pharma major, is upbeat on the European markets, following its two key acquisitions in 2006. With the UK-based Milpharm Ltd and the Netherlands-based Pharmacin International in its fold, the company expects to substantially boost its revenues in the fiscal 2007-08.

The Hyderabad-based Aurobindo Pharma, with strengths in generic pharmaceuticals and active pharmaceutical ingredients (APIs), hopes to gain on two counts through these acquisitions. First, it would quickly achieve a large portfolio of products with regulatory approvals in Europe. Secondly, it would gain new markets and reach them faster.

Contd on page 2......